T3	outcome 1436 1455	treatment causality
T4	outcome 1291 1338	Asymptomatic left ventricular dysfunction (LVD)
T5	iv-bin-abs 1358 1360	18
T6	cv-bin-abs 1391 1394	one
T8	total-participants 622 648	One hundred fifty patients
T9	intervention-participants 662 664	65
T10	control-participants 679 681	85
T12	control 666 673	FEC 100
T13	eligibility 186 213	node-positive breast cancer
T14	location 215 221	French
T15	iv-bin-abs 1153 1157	five
T16	iv-bin-abs 1195 1198	two
T18	intervention 74 160	fluorouracil, epirubicin, and cyclophosphamide, with either 50 or 100 mg of epirubicin
T1	outcome 1127 1149	LVEF was less than 50%
T2	outcome 1220 1250	congestive heart failure (CHF)
